Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

VIP Deficient Mice Exhibit Resistance to Lipopolysaccharide Induced Endotoxemia with an Intrinsic Defect in Proinflammatory Cellular Responses.
[Application of laser therapy in the physiotherapy of patients with multiple sclerosis].
Prostaglandin E2 inhibits IL-23 and IL-12 production by human monocytes through down-regulation of their common p40 subunit.
7T MRI in natalizumab-associated PML and ongoing MS disease activity: A case study.
No Help from Dalfampridine in MS-Related Optic Neuritis
A RARE CASE OF ODONTOGENIC PARAINFECTIOUS INTRAORBITAL OPTIC NEURITIS WITH THE ABSENCE OF CLINICAL MANIFESTATION OF ORBITAL CELLULITIS.
[Treatment of nausea and vomiting with 5HT3 receptor antagonists, steroids, antihistamines, anticholinergics, somatostatinantagonists, benzodiazepines and cannabinoids in palliative care patients : A systematic review.]
Antidepressant activity of fingolimod in mice.
Increase of complement fragment C5a in cerebrospinal fluid during exacerbation of neuromyelitis optica.
Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment.
Cyclophosphamide in chronic progressive multiple sclerosis: a comparative study.
The treatment of spasticity with Delta9-tetrahydrocannabinol in persons with spinal cord injury.
Letter to the Editor.
Lipocalin 2 is a novel immune mediator of experimental autoimmune encephalomyelitis pathogenesis and is modulated in multiple sclerosis.
Curcuminoids in Neurodegenerative Diseases.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Afferent visual pathways in multiple sclerosis: a review.
Rhythmic auditory cueing to improve walking in patients with neurological conditions other than Parkinson's disease - what is the evidence?
Response: relationship between vitamin D and depression in multiple sclerosis.
Regional Distribution and Evolution of Gray Matter Damage in Different Populations of Multiple Sclerosis Patients.
Alemtuzumab as Remission Induction Therapy in Behçet Disease: A 20-year Experience.
Expression of Ccl11 Associates with Immune Response Modulation and Protection against Neuroinflammation in Rats.
Poly-ε-caprolactone microspheres as a drug delivery system for cannabinoid administration: Development, characterization and in vitro evaluation of their antitumoral efficacy.
Improved operator agreement and efficiency using the minimum area contour change method for delineation of hyperintense multiple sclerosis lesions on FLAIR MRI.
Review of the novelties presented at the 29th Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) (III).

Pages